PDCD1 and cancer: Furthermore, SARS-CoV-2 exploits IC pathways, as evidenced by the overexpression of inhibitory receptors like PD-1, CTLA4, Tim3, and LAG3, which drive T cell exhaustion and impair immune surveillance.106 These mechanisms may compromise antitumor immunity and facilitate cancer progression.